226 related articles for article (PubMed ID: 19696399)
1. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
Seeger FH; Rasper T; Koyanagi M; Fox H; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1802-9. PubMed ID: 19696399
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis.
Shiba Y; Takahashi M; Hata T; Murayama H; Morimoto H; Ise H; Nagasawa T; Ikeda U
Cardiovasc Res; 2009 Jan; 81(1):169-77. PubMed ID: 18791205
[TBL] [Abstract][Full Text] [Related]
3. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
[TBL] [Abstract][Full Text] [Related]
7. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells.
Urbich C; Heeschen C; Aicher A; Dernbach E; Zeiher AM; Dimmeler S
Circulation; 2003 Nov; 108(20):2511-6. PubMed ID: 14581410
[TBL] [Abstract][Full Text] [Related]
8. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.
de Nigris F; Balestrieri ML; Williams-Ignarro S; D'Armiento FP; Lerman LO; Byrns R; Crimi E; Palagiano A; Fatigati G; Ignarro LJ; Napoli C
J Cardiovasc Pharmacol; 2007 Oct; 50(4):424-33. PubMed ID: 18049311
[TBL] [Abstract][Full Text] [Related]
10. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy.
You D; Waeckel L; Ebrahimian TG; Blanc-Brude O; Foubert P; Barateau V; Duriez M; Lericousse-Roussanne S; Vilar J; Dejana E; Tobelem G; Lévy BI; Silvestre JS
Circulation; 2006 Jul; 114(4):328-38. PubMed ID: 16847153
[TBL] [Abstract][Full Text] [Related]
11. CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.
Bonaros N; Sondermeijer H; Schuster M; Rauf R; Wang SF; Seki T; Skerrett D; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1044-53. PubMed ID: 18954648
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
[TBL] [Abstract][Full Text] [Related]
14. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method.
Hamano K; Li TS; Kobayashi T; Tanaka N; Kobayashi S; Matsuzaki M; Esato K
Surgery; 2001 Jul; 130(1):44-54. PubMed ID: 11436011
[TBL] [Abstract][Full Text] [Related]
15. Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice.
Vulesevic B; McNeill B; Geoffrion M; Kuraitis D; McBane JE; Lochhead M; Vanderhyden BC; Korbutt GS; Milne RW; Suuronen EJ
Cardiovasc Res; 2014 Feb; 101(2):306-16. PubMed ID: 24259499
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization.
Goukassian DA; Qin G; Dolan C; Murayama T; Silver M; Curry C; Eaton E; Luedemann C; Ma H; Asahara T; Zak V; Mehta S; Burg A; Thorne T; Kishore R; Losordo DW
Circulation; 2007 Feb; 115(6):752-62. PubMed ID: 17261656
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.
Sasaki K; Heeschen C; Aicher A; Ziebart T; Honold J; Urbich C; Rossig L; Koehl U; Koyanagi M; Mohamed A; Brandes RP; Martin H; Zeiher AM; Dimmeler S
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14537-41. PubMed ID: 16983080
[TBL] [Abstract][Full Text] [Related]
18. Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration.
Shao H; Xu Q; Wu Q; Ma Q; Salgueiro L; Wang J; Eton D; Webster KA; Yu H
J Cell Mol Med; 2011 Oct; 15(10):2046-56. PubMed ID: 21143386
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.
Carr AN; Howard BW; Yang HT; Eby-Wilkens E; Loos P; Varbanov A; Qu A; DeMuth JP; Davis MG; Proia A; Terjung RL; Peters KG
Cardiovasc Res; 2006 Mar; 69(4):925-35. PubMed ID: 16409996
[TBL] [Abstract][Full Text] [Related]
20. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K
Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
